Cargando…
Management of Progressive Radioiodine-Refractory Thyroid Carcinoma: Current Perspective
Patients with thyroid cancer (TC) usually have an excellent prognosis; however, 5–10% of them develop an advanced disease. The prognosis of this subgroup is still favourable if the lesions respond to radioactive iodine (RAI) treatment. Nearly two-thirds of advanced TC patients become RAI-refractory...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584766/ https://www.ncbi.nlm.nih.gov/pubmed/36275786 http://dx.doi.org/10.2147/CMAR.S340967 |